Cargando…
Leishmania donovani Nucleoside Hydrolase (NH36) Domains Induce T-Cell Cytokine Responses in Human Visceral Leishmaniasis
Development of immunoprotection against visceral leishmaniasis (VL) focused on the identification of antigens capable of inducing a Th1 immune response. Alternatively, antigens targeting the CD8 and T-regulatory responses are also relevant in VL pathogenesis and worthy of being included in a prevent...
Autores principales: | Barbosa Santos, Micheli Luize, Nico, Dirlei, de Oliveira, Fabrícia Alvisi, Barreto, Aline Silva, Palatnik-de-Sousa, Iam, Carrillo, Eugenia, Moreno, Javier, de Luca, Paula Mello, Morrot, Alexandre, Rosa, Daniela Santoro, Palatnik, Marcos, Bani-Corrêa, Cristiane, de Almeida, Roque Pacheco, Palatnik-de-Sousa, Clarisa Beatriz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338038/ https://www.ncbi.nlm.nih.gov/pubmed/28321221 http://dx.doi.org/10.3389/fimmu.2017.00227 |
Ejemplares similares
-
Leishmania donovani Nucleoside Hydrolase Terminal Domains in Cross-Protective Immunotherapy Against Leishmania amazonensis Murine Infection
por: Nico, Dirlei, et al.
Publicado: (2014) -
A Chimera Containing CD4+ and CD8+ T-Cell Epitopes of the Leishmania donovani Nucleoside Hydrolase (NH36) Optimizes Cross-Protection against Leishmania amazonesis Infection
por: Alves-Silva, Marcus Vinícius, et al.
Publicado: (2017) -
Cross-Protective Immunity to Leishmania amazonensis is Mediated by CD4+ and CD8+ Epitopes of Leishmania donovani Nucleoside Hydrolase Terminal Domains
por: Nico, Dirlei, et al.
Publicado: (2014) -
The F1F3 Recombinant Chimera of Leishmania donovani-Nucleoside Hydrolase (NH36) and Its Epitopes Induce Cross-Protection Against Leishmania (V.) braziliensis Infection in Mice
por: Alves-Silva, Marcus Vinícius, et al.
Publicado: (2019) -
Nucleoside Hydrolase NH 36: A Vital Enzyme for the Leishmania Genus in the Development of T-Cell Epitope Cross-Protective Vaccines
por: Palatnik-de-Sousa, Clarisa Beatriz
Publicado: (2019)